Advertisement
Canada markets close in 12 minutes

  • S&P/TSX

    22,020.37
    +148.41 (+0.68%)
     

  • S&P 500

    5,070.83
    +60.23 (+1.20%)
     

  • DOW

    38,504.11
    +264.13 (+0.69%)
     

  • CAD/USD

    0.7321
    +0.0020 (+0.27%)
     

  • CRUDE OIL

    83.35
    +1.45 (+1.77%)
     

  • Bitcoin CAD

    90,882.18
    +135.62 (+0.15%)
     

  • CMC Crypto 200

    1,431.64
    +16.88 (+1.19%)
     

  • GOLD FUTURES

    2,336.00
    -10.40 (-0.44%)
     

  • RUSSELL 2000

    2,003.18
    +35.71 (+1.82%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ

    15,705.23
    +253.92 (+1.64%)
     

  • VOLATILITY

    15.81
    -1.13 (-6.67%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Aphria (APHA) Looks Good: Stock Adds 8.8% in Session

Zacks Equity Research
·2 min read

Aphria Inc. APHA was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.07 to $4.45 in the past one-month time frame.

The company has seen no estimate revisions over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Aphria currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Aphria Inc. Price

Aphria Inc. Price
Aphria Inc. Price

Aphria Inc. price | Aphria Inc. Quote

ADVERTISEMENT

 

A better-ranked stock in the Medical sector is Abbott Laboratories ABT, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Abbott Laboratories (ABT) : Free Stock Analysis Report
 
Aphria Inc. (APHA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research